arrow
C

Carlos Rangel Rodrigues

Universidade Federal do Rio de Janeiro
H指数:39
被引数:5,449

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Integrative in silico and in vitro discovery of a novel thiazolidinone derivative as arginase inhibitor with potent antileishmanial activity

通过整合计算与体外方法发现一种新型噻唑烷酮衍生物作为精氨酸酶抑制剂,并具有强效抗利什曼原虫活性

2026-07-010
PRE
Piperazine-Thiourea Hybrids as Novel Antiplatelet Agents Targeting COX-1: Synthesis; in Vitro; and in Silico Evaluation

哌嗪-硫脲类杂合体作为靶向COX-1的新型抗血小板剂:合成;体外;和计算机模拟评价

2026-04-010
OA
Sleep Habits, Physical Exercise, and Social Media Use and Their Influence on Perceptions of Physical and Mental Health-Case Study at a Higher Education Institution in Portugal

睡眠习惯、体育锻炼和社交媒体使用及其对身体健康和心理健康感知的影响——葡萄牙某高等教育机构案例研究

2026-01-290
OAAI
Unveiling Novel Arginase Inhibitors for Cutaneous Leishmaniasis Using Drug Repurposing and Virtual Screening Approaches

利用药物重定位和虚拟筛选方法揭示新型精氨酸酶抑制剂以治疗皮肤利什曼病

2025-08-220
OAAI
Statine-based peptidomimetics as SARS-CoV-2 Papain-like protease inhibitors: in Silico and in vitro studies

基于Statine的肽模拟物作为SARS-CoV-2木瓜蛋白酶样蛋白酶抑制剂:计算和体外研究

2025-07-200
OA
Synthesis, in silico, and in vitro evaluation of 7-chloro-quinolines designed as myeloperoxidase inhibitors
2024-09-010
PRE
Statine-based peptidomimetic compounds as inhibitors for SARS-CoV-2 main protease (SARS-CoV-2 Mpro)
2024-04-182
OAAI
Novel naphthoquinone-1H-1,2,3-triazole hybrids: Design, synthesis and evaluation as inductors of ROS-mediated apoptosis in the MCF-7 cells
2024-03-018
PRE